NOVEL PHARMACOTHERAPIES FOR ALCOHOLISM, TOPIC #4409/24/2012 - 03/23/2013

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$149,697.00
Award Year:
2012
Program:
SBIR
Phase:
Phase I
Contract:
N43AA120010
Award Id:
n/a
Agency Tracking Number:
N43AA120010
Solicitation Year:
2012
Solicitation Topic Code:
NIAAA
Solicitation Number:
n/a
Small Business Information
Naprogenix, Inc., KTRDC - U.K. - AgTecc Laboratories, Lexington, KY, 40546-0236
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
196165877
Principal Investigator:
JOHN LITTLETON
(859) 257-1127
JLITTLET@UKY.EDU
Business Contact:
JOHN LITTLETON
(859) 257-1127
JLITTLET@UKY.EDU
Research Institution:
Stub




Abstract
Alcoholism is a complex condition in which there are many potential molecular and therapeutic targets for pharmacotherapy. This fast track SBIR contract aims to investigate compounds targeted on the glutamate/NMDA receptor (NMDAR) and the nicotinic receptor for acetylcholine (nicAChR). These targets have direct relevance to several of the major therapeutic targets including detoxification of acute withdrawal, neurotoxicity, relapse, organ damage, co-morbid neuropathic pain, and co-morbid drug abuse (including smoking). Naprogenix first identifies synthetic drugs or plant metabolites by high throughput pharmacological screening, prioritizing lead compounds which have valuable multifunctionality. Leads are then tested in whole animal screens and models reflecting different specific aspects of alcoholism and the most promising are optimized by synthetic modification, or by a novel plant genomic approach. Phase 1 of this fast track proposal is to complete preliminary studies at the molecular level on the4 current best therapeutic candidates (2 synthetics and 2 natural products), and to prepare sufficient quantities of these for cellular studies and whole animal evaluation in phase 2. Also during phase 2, the company, with the National Institute on AlcoholAbuse and Alcoholism (NIAAA), will contact major pharmaceutical and nutritional companies to explore the further development of these compounds as medications or nutraceuticals.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government